Glenmark Pharmaceuticals Has Been Granted Approval By The United States Food & Drug Administration (Usfda) For Its Lacosamide Tablets 1 Usp, 50 Mg, 100 Mg, 150 Mg And 200 Mg Of Ucb, Inc. The Company Plans To Launch The Product Immediately. Commenting On The Development, Robert Crockart, Chief Commercial Officer, Glenmark Pharmaceuticals Ltd, Said,
